1. Home
  2. NEO vs GRC Comparison

NEO vs GRC Comparison

Compare NEO & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEO
  • GRC
  • Stock Information
  • Founded
  • NEO 2001
  • GRC 1933
  • Country
  • NEO United States
  • GRC United States
  • Employees
  • NEO N/A
  • GRC N/A
  • Industry
  • NEO Precision Instruments
  • GRC Fluid Controls
  • Sector
  • NEO Health Care
  • GRC Industrials
  • Exchange
  • NEO Nasdaq
  • GRC Nasdaq
  • Market Cap
  • NEO 902.1M
  • GRC 1.0B
  • IPO Year
  • NEO 1999
  • GRC N/A
  • Fundamental
  • Price
  • NEO $7.53
  • GRC $38.75
  • Analyst Decision
  • NEO Buy
  • GRC
  • Analyst Count
  • NEO 9
  • GRC 0
  • Target Price
  • NEO $13.31
  • GRC N/A
  • AVG Volume (30 Days)
  • NEO 2.2M
  • GRC 55.6K
  • Earning Date
  • NEO 07-29-2025
  • GRC 07-25-2025
  • Dividend Yield
  • NEO N/A
  • GRC 1.91%
  • EPS Growth
  • NEO N/A
  • GRC 21.97
  • EPS
  • NEO N/A
  • GRC 1.69
  • Revenue
  • NEO $672,361,000.00
  • GRC $664,347,000.00
  • Revenue This Year
  • NEO $13.97
  • GRC $4.50
  • Revenue Next Year
  • NEO $11.36
  • GRC $4.50
  • P/E Ratio
  • NEO N/A
  • GRC $22.91
  • Revenue Growth
  • NEO 10.10
  • GRC 0.92
  • 52 Week Low
  • NEO $6.08
  • GRC $30.87
  • 52 Week High
  • NEO $19.12
  • GRC $43.79
  • Technical
  • Relative Strength Index (RSI)
  • NEO 52.96
  • GRC 65.57
  • Support Level
  • NEO $7.04
  • GRC $36.65
  • Resistance Level
  • NEO $7.73
  • GRC $38.44
  • Average True Range (ATR)
  • NEO 0.35
  • GRC 0.77
  • MACD
  • NEO 0.08
  • GRC 0.28
  • Stochastic Oscillator
  • NEO 79.78
  • GRC 97.43

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

Share on Social Networks: